Colgate-Palmolive (CL) is back on investor radars after recent trading data highlighted its share performance over the past month and past 3 months. This is prompting a closer look at what the current pricing might imply.

At a share price of $91.88, Colgate-Palmolive has recorded a 9.2% 3 month share price return and an 18.3% year to date share price return. The 3 year total shareholder return of 29.9% points to steady long term compounding and suggests momentum has been building recently.

If Colgate-Palmolive’s recent move has you thinking about what else is working in defensives, it could be a good moment to broaden your search with the 20 top founder-led companies

So with Colgate-Palmolive trading at $91.88 alongside an indicated intrinsic discount of 23.5%, should you see this as a genuine value gap, or are markets already baking in the company’s future growth potential?

Most Popular Narrative: 5% Undervalued

Colgate-Palmolive's most followed narrative points to a fair value of about $96.68, compared with the recent $91.88 share price, putting the focus firmly on whether its long term plan justifies that gap.

Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll out of complementary products across 75 markets, are set to capture increased value from emerging middle class consumers and rising health/hygiene awareness globally, supporting top line organic sales acceleration and improved pricing power.

Want to understand why this Colgate-Palmolive narrative supports a higher price tag? It hinges on measured revenue growth, higher margins, and a richer earnings mix that leans on everyday categories and a premium P/E assumption, all tied together with a specific discount rate.

Result: Fair Value of $96.68 (UNDERVALUED)

However, this Colgate-Palmolive narrative could be knocked off course if higher raw material costs squeeze margins, or if softer demand in key markets keeps volume growth under pressure.

Another View On Colgate-Palmolive’s Valuation

While the narrative and analyst targets frame Colgate-Palmolive as trading below fair value, the current P/E of 35.2x tells a different story. It is much higher than the estimated fair ratio of 21.3x, the peer average of 22.4x, and the global Household Products industry at 17.5x.

In practical terms, you are paying a premium price today for the company’s earnings compared with both peers and where the fair ratio indicates the multiple could move toward over time. This raises the question of how much future execution is already reflected in the current valuation.

Next Steps

Mixed on Colgate-Palmolive after all this, or already leaning one way? Act while the details are fresh, review both the upside and the concerns, then weigh the 3 key rewards and 3 important warning signs.

Looking For More Investment Ideas Beyond Colgate-Palmolive?

If Colgate-Palmolive has sharpened your focus on quality, do not stop here. Broaden your watchlist with fresh ideas that could reshape how you think about your portfolio.

• Target steady compounding potential by checking out income opportunities across 7 dividend fortresses built around higher yields and resilient cash generation.
• Hunt for strong businesses priced below what their fundamentals suggest by scanning the 44 high quality undervalued stocks that bring quality and value together.
• Prioritise resilience and capital preservation by reviewing 70 resilient stocks with low risk scores that pair lower risk scores with solid underlying performance.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.